Yaz
Generic Name: Drospirenone and Ethinyl Estradiol
Seek Urgent Medical Attention If:
You experience severe allergic reaction symptoms (swelling of the face, lips, tongue, or throat causing difficulty breathing), severe rash with skin peeling, sudden intense chest pain, or symptoms of overdose. Call emergency medical services immediately.
Uses & Medical Indications
Prevention of pregnancy; treatment of symptoms of premenstrual dysphoric disorder (PMDD); treatment of moderate acne vulgaris in females >= 14 years.
Oral Contraception, Premenstrual Dysphoric Disorder (PMDD), Moderate Acne Vulgaris
Dosage & Administration Guidelines
One tablet orally daily at the exact same time every day for 28 consecutive days.
Approved for post-menarche females under healthcare supervision.
Not indicated in postmenopausal women.
1 tablet daily.
Contraindicated in renal impairment due to drospirenone's antimineralocorticoid properties.
Contraindicated in acute or severe hepatic disease.
Side Effects & Safety Warnings
Nausea, breast tenderness, breakthrough bleeding, headache, mood swings.
Venous thromboembolism (DVT/PE), arterial thromboembolism (stroke, MI), hyperkalemia, gallbladder disease.
Smokers >35 years, deep vein thrombosis history, breast cancer, uncontrolled hypertension.
Black Box Warning: Cigarette smoking increases risk of serious cardiovascular events in women over 35.
Interactions (Drugs, Food & Alcohol)
Drugs that increase serum potassium (ACE inhibitors, ARBs, potassium-sparing diuretics), CYP3A4 inducers (St. John's wort, rifampin).
Avoid excessive potassium intake.
No direct chemical interaction.
Pregnancy & Breastfeeding Safety
Contraindicated in verified pregnancy; discontinue if pregnancy is confirmed.
May decrease breast milk volume; not recommended until weaning.
Patient Counseling & Practical Advice
Take at the exact same time every single day. Do not smoke while taking this medication.
Follow package instructions strictly regarding missed pill rules and use backup contraception.
Blood pressure, serum potassium during first month if taking concurrent potassium-raising drugs.
Content for Yaz was synthesized and fact-checked against standardized regulatory monographs, official pharmacopoeias, and national health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines 23rd List
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.